Both in Pharmaceuticals
PUMA BIOTECHNOLOGY vs Ovid Therapeutics
Over the past year PBYI returned +90.6% and OVID returned +48.1%; their daily moves had a correlation of 0.11.
PBYI +90.6% OVID +48.1%Growth of $1, one year, split-adjusted
| Metric | PBYI | OVID |
|---|---|---|
| Price | $9.97 | $2.34 |
| Market cap | $514.7M | $457.0M |
| Today | +1.63% | −0.85% |
| 1 month | +10.2% | −13.3% |
| 6 months | +27.8% | −18.8% |
| Year to date | +67.6% | +43.6% |
| 1 year | +92.5% | +40.1% |
| Revenue growth (YoY) | +7.8% | −88.3% |
| Gross margin | 77.9% | 100.0% |
| Net margin | 14.5% | −2047.6% |
| P/E (TTM) | 19.3× | — |
| Price / sales | 2.2× | 288.7× |
| Net cash | $93.9M | $117.2M |
| Dividend yield | — | — |
| Volatility (60d) | 43.1% | 49.1% |
| Short % of float | 11.2% | 13.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).